Stop rushing, start knowing. Remember to look down before you run.
The Job In consulting, people love momentum. New project? Great. Let’s get moving. While it’s lovely for teams and stakeholders to feel enthused, rushing to execution without understanding the ground beneath your feet isn’t momentum, it’s reckless optimism disguised as progress.. Before you plot the destination, you need a clear picture of where you’re standing. That’s true for any change, but in pharma M&A the information burden is on another level entirely. The more you uncover, the safer you are, because every extra scrap of detail is one less ambush in the form of cost blow-outs, delays, regulatory problems or the whole delightful package at once. Over the years I’ve built and rebuilt my own due-diligence framework. Every time something hasn’t gone to plan on a deal, one of the root causes is nearly always we didn’t have the facts early enough. Here’s my run-down of the areas you need to lock down. 1. Product Landscape You are not buying a brand, you’re buying its operation...
